MedPath

Albendazole

Generic Name
Albendazole
Brand Names
Albenza
Drug Type
Small Molecule
Chemical Formula
C12H15N3O2S
CAS Number
54965-21-8
Unique Ingredient Identifier
F4216019LN

Overview

A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)

Background

A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)

Indication

For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Associated Conditions

  • Hydatid disease of the Liver
  • Hydatid disease of the Lung
  • Hydatid disease of the Peritoneum
  • Neurocysticercosis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/09/26
Phase 3
Not yet recruiting
Programme National de Lutte contre l'Onchocercose, Republic of the Congo
2024/08/22
Phase 2
Not yet recruiting
2024/07/11
N/A
Completed
Jennifer Keiser
2024/07/03
Not Applicable
Recruiting
2024/04/19
Phase 4
Not yet recruiting
R-Evolution Worldwide S.r.l. Impresa Sociale
2024/02/20
Not Applicable
Not yet recruiting
2024/01/11
Phase 1
Completed
2024/01/03
Phase 3
Completed
Jennifer Keiser
2023/12/28
Phase 2
Completed
Jennifer Keiser
2023/07/17
Not Applicable
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Bryant Ranch Prepack
72162-1309
ORAL
200 mg in 1 1
8/25/2023
Novadoz Pharmaceuticals LLC
72205-051
ORAL
200 mg in 1 1
2/1/2020
Actavis Pharma, Inc.
0591-2712
ORAL
200 mg in 1 1
7/31/2019
Zydus Lifesciences Limited
70771-1103
ORAL
200 mg in 1 1
10/13/2022
Amneal Pharmaceuticals LLC
64896-693
ORAL
200 mg in 1 1
12/16/2023
Amneal Pharmaceuticals of New York LLC
0115-1701
ORAL
200 mg in 1 1
9/30/2019
Zydus Pharmaceuticals USA Inc.
70710-1021
ORAL
200 mg in 1 1
11/6/2022
Cipla USA Inc.
69097-237
ORAL
200 mg in 1 1
12/5/2022
Bryant Ranch Prepack
63629-1221
ORAL
200 mg in 1 1
6/15/2020
MSN LABORATORIES PRIVATE LIMITED
69539-151
ORAL
200 mg in 1 1
1/25/2021

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
Zentel Tablet 400mg
SIN14030P
TABLET, CHEWABLE
400 mg
10/18/2011
ALZENTAL TABLET 400 mg
SIN07903P
TABLET, FILM COATED
400 mg
11/9/1994
ALBENDOL-400 TABLET 400 mg
SIN09954P
TABLET
400 mg
8/22/1998

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Albendazole Capsules
国药准字H51020135
化学药品
胶囊剂
2/5/2020
Albendazole Capsules
国药准字H11021474
化学药品
胶囊剂
9/9/2020
Albendazole Capsules
国药准字H41022816
化学药品
胶囊剂
4/15/2025
Albendazole Capsules
国药准字H51020134
化学药品
胶囊剂
2/5/2020
Albendazole Capsules
国药准字H20045572
化学药品
胶囊剂
8/10/2020
Albendazole Capsules
国药准字H51021185
化学药品
胶囊剂
1/8/2021
Albendazole Capsules
国药准字H31020015
化学药品
胶囊剂
3/2/2020
Albendazole Capsules
国药准字H33020728
化学药品
胶囊剂
4/30/2020
Albendazole Capsules
国药准字H20054596
化学药品
胶囊剂
12/14/2020
Albendazole Capsules
国药准字H50020300
化学药品
胶囊剂
4/20/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath